PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SNEX vs. CCAP
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SNEX and CCAP is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

SNEX vs. CCAP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in StoneX Group Inc. (SNEX) and Crescent Capital BDC, Inc. (CCAP). The values are adjusted to include any dividend payments, if applicable.

0.00%10.00%20.00%30.00%40.00%50.00%60.00%SeptemberOctoberNovemberDecember2025February
56.01%
15.29%
SNEX
CCAP

Key characteristics

Sharpe Ratio

SNEX:

3.05

CCAP:

2.55

Sortino Ratio

SNEX:

3.84

CCAP:

3.44

Omega Ratio

SNEX:

1.48

CCAP:

1.48

Calmar Ratio

SNEX:

6.45

CCAP:

3.56

Martin Ratio

SNEX:

19.66

CCAP:

12.14

Ulcer Index

SNEX:

4.33%

CCAP:

2.97%

Daily Std Dev

SNEX:

27.96%

CCAP:

14.16%

Max Drawdown

SNEX:

-97.68%

CCAP:

-63.68%

Current Drawdown

SNEX:

0.00%

CCAP:

-0.02%

Fundamentals

Market Cap

SNEX:

$4.00B

CCAP:

$741.04M

EPS

SNEX:

$8.37

CCAP:

$2.56

PE Ratio

SNEX:

14.89

CCAP:

7.81

Total Revenue (TTM)

SNEX:

$108.25B

CCAP:

$147.23M

Gross Profit (TTM)

SNEX:

$29.39B

CCAP:

$127.78M

EBITDA (TTM)

SNEX:

$1.68B

CCAP:

$80.72M

Returns By Period

In the year-to-date period, SNEX achieves a 27.17% return, which is significantly higher than CCAP's 4.03% return.


SNEX

YTD

27.17%

1M

18.65%

6M

57.15%

1Y

85.90%

5Y*

30.10%

10Y*

22.24%

CCAP

YTD

4.03%

1M

3.39%

6M

15.17%

1Y

36.25%

5Y*

16.47%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SNEX vs. CCAP — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SNEX
The Risk-Adjusted Performance Rank of SNEX is 9797
Overall Rank
The Sharpe Ratio Rank of SNEX is 9898
Sharpe Ratio Rank
The Sortino Ratio Rank of SNEX is 9595
Sortino Ratio Rank
The Omega Ratio Rank of SNEX is 9494
Omega Ratio Rank
The Calmar Ratio Rank of SNEX is 9999
Calmar Ratio Rank
The Martin Ratio Rank of SNEX is 9797
Martin Ratio Rank

CCAP
The Risk-Adjusted Performance Rank of CCAP is 9494
Overall Rank
The Sharpe Ratio Rank of CCAP is 9696
Sharpe Ratio Rank
The Sortino Ratio Rank of CCAP is 9494
Sortino Ratio Rank
The Omega Ratio Rank of CCAP is 9494
Omega Ratio Rank
The Calmar Ratio Rank of CCAP is 9696
Calmar Ratio Rank
The Martin Ratio Rank of CCAP is 9393
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SNEX vs. CCAP - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for StoneX Group Inc. (SNEX) and Crescent Capital BDC, Inc. (CCAP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SNEX, currently valued at 3.05, compared to the broader market-2.000.002.003.052.55
The chart of Sortino ratio for SNEX, currently valued at 3.84, compared to the broader market-4.00-2.000.002.004.006.003.843.44
The chart of Omega ratio for SNEX, currently valued at 1.48, compared to the broader market0.501.001.502.001.481.48
The chart of Calmar ratio for SNEX, currently valued at 6.45, compared to the broader market0.002.004.006.006.453.56
The chart of Martin ratio for SNEX, currently valued at 19.66, compared to the broader market0.0010.0020.0030.0019.6612.14
SNEX
CCAP

The current SNEX Sharpe Ratio is 3.05, which is comparable to the CCAP Sharpe Ratio of 2.55. The chart below compares the historical Sharpe Ratios of SNEX and CCAP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.001.502.002.503.00SeptemberOctoberNovemberDecember2025February
3.05
2.55
SNEX
CCAP

Dividends

SNEX vs. CCAP - Dividend Comparison

SNEX has not paid dividends to shareholders, while CCAP's dividend yield for the trailing twelve months is around 10.20%.


TTM20242023202220212020
SNEX
StoneX Group Inc.
0.00%0.00%0.00%0.00%0.00%0.00%
CCAP
Crescent Capital BDC, Inc.
10.20%10.61%10.41%14.01%9.60%11.26%

Drawdowns

SNEX vs. CCAP - Drawdown Comparison

The maximum SNEX drawdown since its inception was -97.68%, which is greater than CCAP's maximum drawdown of -63.68%. Use the drawdown chart below to compare losses from any high point for SNEX and CCAP. For additional features, visit the drawdowns tool.


-12.00%-10.00%-8.00%-6.00%-4.00%-2.00%0.00%SeptemberOctoberNovemberDecember2025February0
-0.02%
SNEX
CCAP

Volatility

SNEX vs. CCAP - Volatility Comparison

StoneX Group Inc. (SNEX) has a higher volatility of 10.35% compared to Crescent Capital BDC, Inc. (CCAP) at 3.14%. This indicates that SNEX's price experiences larger fluctuations and is considered to be riskier than CCAP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%SeptemberOctoberNovemberDecember2025February
10.35%
3.14%
SNEX
CCAP

Financials

SNEX vs. CCAP - Financials Comparison

This section allows you to compare key financial metrics between StoneX Group Inc. and Crescent Capital BDC, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab